MUSSO, MARGARET ROBERTA
 Distribuzione geografica
Continente #
NA - Nord America 135
AS - Asia 61
EU - Europa 50
AF - Africa 16
SA - Sud America 6
OC - Oceania 2
Totale 270
Nazione #
US - Stati Uniti d'America 129
SG - Singapore 41
IT - Italia 21
CI - Costa d'Avorio 10
IE - Irlanda 10
CN - Cina 7
BR - Brasile 4
CA - Canada 4
RU - Federazione Russa 4
SN - Senegal 4
DE - Germania 3
GB - Regno Unito 3
IN - India 3
VN - Vietnam 3
AU - Australia 2
HK - Hong Kong 2
MX - Messico 2
NG - Nigeria 2
NL - Olanda 2
SA - Arabia Saudita 2
UA - Ucraina 2
AR - Argentina 1
AT - Austria 1
CO - Colombia 1
FI - Finlandia 1
FR - Francia 1
JO - Giordania 1
PK - Pakistan 1
PL - Polonia 1
SE - Svezia 1
TR - Turchia 1
Totale 270
Città #
Santa Clara 37
Singapore 33
Chandler 17
Chicago 13
Abidjan 10
Dublin 10
Civitanova Marche 6
Igea Marina 6
Los Angeles 5
Beijing 4
Boardman 4
Dakar 4
Andover 3
Ashburn 3
Cambridge 3
Dallas 3
Des Moines 3
Jacksonville 3
Lawrence 3
New York 3
São Paulo 3
Abuja 2
Boston 2
Catania 2
Dong Ket 2
Kochi 2
Mexico City 2
Pisa 2
Toronto 2
Adana 1
Amman 1
Ancona 1
Bremen 1
Bronte 1
Brooklyn 1
Glasgow 1
Groningen 1
Hong Kong 1
Hyde Park 1
Jeddah 1
Joliet 1
Khobar 1
Lahore 1
Medellín 1
Montreal 1
Munich 1
Nuremberg 1
Ottawa 1
Phoenix 1
Phủ Lý 1
Pouso Alegre 1
Sacramento 1
Saint Petersburg 1
San Francisco 1
Suzhou 1
The Dalles 1
Turku 1
Villa Constitución 1
Totale 221
Nome #
Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST Study 85
Differences among young adults, adults and elderly chronic myeloid leukemia patients 65
Brentuximab vedotin in association with bendamustine in refractory or multiple relapsed Hodgkin lymphoma. A retrospective real-world study 63
Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial 29
Treatment simplification to atazanavir/ritonavir+lamivudine versus maintenance of atazanavir/ritonavir+two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M) 24
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 12
Totale 278
Categoria #
all - tutte 1.349
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.349


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202118 0 0 1 0 1 1 2 0 0 2 1 10
2021/202220 2 3 0 0 5 0 3 0 0 0 1 6
2022/202350 3 7 0 4 6 5 0 7 12 0 2 4
2023/202422 1 6 0 0 2 5 0 0 0 0 5 3
2024/2025131 3 22 8 10 27 19 3 0 6 11 12 10
2025/202632 18 12 2 0 0 0 0 0 0 0 0 0
Totale 278